Home Newsfeeds Baird Maintains Outperform on IDEAYA Biosciences, Raises Price Target to $24

Baird Maintains Outperform on IDEAYA Biosciences, Raises Price Target to $24

Baird analyst Joel Beatty maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and raises the price target from $18 to $24.

byBenzinga Newsdesk

November 18, 2022

1 minute read

Baird analyst Joel Beatty maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and raises the price target from $18 to $24.

Jim Cramer On ‘Fed Heads’ That Want To Raise Rates: They Want To ‘Tip Us Into A Definitive Recession’

By Bhavik Nair

June 1, 2:27 AM

Prominent market commentator Jim Cramer reportedly told investors on Wednesday the Federal Reserve needs to calm down and…

QQQ

Reported Late Tuesday March 14, Accelerate Diagnostics Announces Departure Of CFOSteve Reichling And Appointment Of David Patience As Replacement Effective April 1, 2023

By Happy Mohamed

March 15, 1:11 AM

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) a leading provider of innovative rapid diagnostic solutions, announced today that Steve Reichling will be stepping down as Chief Financial Officer (CFO),

AXDX

Blue Bird Delivers 20 Electric School Buses To Miami-Dade County Public Schools In Florida

By Happy Mohamed

August 15, 11:02 AM

First Zero-emission Vehicles in School Districts' All Blue Bird School Bus Fleet Blue Bird Corporation (NASDAQ:BLBD), the leader in electric and low-emission school buses, is supplying 20 electric school buses to

BLBD

Cheaper Alternatives of Weight-Loss Drugs? Chinese Pharma Companies Are Working On a Local Version

By Vandana Singh

August 16, 9:15 AM

Chinese pharma firms are reportedly working on producing local equivalents of advanced weight-loss medications, challenging Western pharmaceutical giants in a

AZN

Baird Maintains Outperform on IDEAYA Biosciences, Raises Price Target to $24

Related Posts

Jim Cramer On ‘Fed Heads’ That Want To Raise Rates: They Want To ‘Tip Us Into A Definitive Recession’

Reported Late Tuesday March 14, Accelerate Diagnostics Announces Departure Of CFOSteve Reichling And Appointment Of David Patience As Replacement Effective April 1, 2023

Blue Bird Delivers 20 Electric School Buses To Miami-Dade County Public Schools In Florida

Cheaper Alternatives of Weight-Loss Drugs? Chinese Pharma Companies Are Working On a Local Version